Neuropsychological impairment is a form of dysfunction that is related to the interaction between the brain and behaviour, perceptions, emotions, and cognitions. It is based on the scientific field of neuropsychology, which is an integration of clinical psychology, neuroscience, and physiology. Generally, neuropsychological impairment is seen as an alteration or disruption in intellectual functioning, memory, language, problem-solving, and other mental skills. The most common causes of neuropsychological impairment are head trauma, stroke, encephalitis, tumours, infections, and degenerative brain diseases. These cause damage to the structures of the brain, either in a localized or widespread way, which can lead to temporary or permanent neuropsychological impairment. The effects of this impairment may vary from person to person, and can include difficulty with multitasking, concentration, and learning. The effects of neuropsychological impairment can range from mild to severe, and can impact a person's daily functioning. Mild cases may affect things such as executive functioning, working memory, and complex problem-solving abilities, whereas more severe cases can impact a person's emotional regulation, self-control, and interpersonal relationship abilities. When assessing individuals with suspected neuropsychological impairment, an experienced neuropsychologist will typically conduct a sequence of carefully tailored tests designed to measure cognitive, emotional, and behavioural functions. The results from these tests can then be used to assess various aspects of functioning, including memory, learning, emotion-regulation, and executive functioning. Depending on the results, a variety of interventions can then be designed, such as manual-guided instruction, cognitive retraining, or behaviour modifications. In general, neuropsychological impairment can be effectively controlled through appropriate interventions. However, due to the complex nature of the disorder, it is important to seek out the guidance of an experienced neuropsychologist in order to ensure that the most effective regimen is prescribed for a patient's individual needs.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom